Amgen (AMGN) Accounts Payables (2016 - 2025)
Historic Accounts Payables for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $2.8 billion.
- Amgen's Accounts Payables rose 3218.44% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 3218.44%. This contributed to the annual value of $1.9 billion for FY2024, which is 2000.0% up from last year.
- Latest data reveals that Amgen reported Accounts Payables of $2.8 billion as of Q3 2025, which was up 3218.44% from $3.0 billion recorded in Q2 2025.
- Amgen's Accounts Payables' 5-year high stood at $3.0 billion during Q2 2025, with a 5-year trough of $1.2 billion in Q3 2021.
- Over the past 5 years, Amgen's median Accounts Payables value was $1.4 billion (recorded in 2022), while the average stood at $1.7 billion.
- In the last 5 years, Amgen's Accounts Payables tumbled by 591.59% in 2023 and then surged by 8704.62% in 2024.
- Over the past 5 years, Amgen's Accounts Payables (Quarter) stood at $1.4 billion in 2021, then increased by 15.08% to $1.6 billion in 2022, then grew by 1.15% to $1.6 billion in 2023, then increased by 20.0% to $1.9 billion in 2024, then skyrocketed by 48.74% to $2.8 billion in 2025.
- Its last three reported values are $2.8 billion in Q3 2025, $3.0 billion for Q2 2025, and $2.4 billion during Q1 2025.